Results 361 to 370 of about 622,897 (403)

Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial. [PDF]

J Infect Dis
Chew KW, McGinley B, Moser C, Li JZ, Evering TH, Ritz J, Javan AC, Margolis D, Wohl DA, Hughes MD, Daar ES, Currier JS, Eron JJ, Smith DM, Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-2/A5401 Study Team, Study Sites, and Investigators.   +16 more
europepmc   +1 more source

Deep Vein Thrombosis in Critically Ill Patients With COVID‐19 Pneumonia

Journal of Ultrasound in Medicine, Volume 45, Issue 1, Page 155-170, January 2026.
Objectives The risk of major venous thromboembolism (VTE) among patients with COVID‐19 is high but varies with disease severity. Estimate the incidence of lower extremity deep venous thrombosis (DVT) in critically ill hospitalized patients with COVID‐19, validate the Wells score for DVT diagnosis, and determine patients' prognosis.
Clévio Cezar da Fonseca, Hugo Perazzo, Sandra Wagner Cardoso, Isabel Cristina Ferreira Tavares, Maria Pia Diniz Ribeiro, Rodrigo de Carvalho Moreira, Lara Esteves Coelho, Emília Moreira Jalil, André Miguel Japiassú, Elias Pimentel Gouvêa, Estevão Portela Nunes, Hugo Boechat Andrade, Luciano Barros Gouvêa, Marcel Treptow Ferreira, Pedro Mendes Azambuja‐Rodrigues, Ronaldo Ismerio Moreira, Kim Mattos Geraldo, Lucilene Araújo de Freitas, Vinicius Velleda Pacheco, Beatriz Gilda Jegerhorn Grinsztein, Pedro Emmanuel Alvarenga Americano do Brasil   +20 more
wiley   +1 more source

Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants. [PDF]

J Infect Dis
Baum HE, Santopaolo M, Francis O, Milodowski EJ, Entwistle K, Oliver E, Hitchings B, Diamond D, Thomas AC, Mitchell RE, Kibble M, Gupta K, Di Bartolo N, Klenerman P, Brown A, Morales-Aza B, Oliver J, Berger I, Toye AM, Finn A, Goenka A, Davidson AD, Ring S, Molloy L, Lewcock M, Northstone K, Roth F, Timpson NJ, Wooldridge L, Halliday A, Rivino L.   +30 more
europepmc   +1 more source

Mapping protein–protein interactions by mass spectrometry

Mass Spectrometry Reviews, Volume 45, Issue 1, Page 69-106, January/February 2026.
Abstract Protein–protein interactions (PPIs) are essential for numerous biological activities, including signal transduction, transcription control, and metabolism. They play a pivotal role in the organization and function of the proteome, and their perturbation is associated with various diseases, such as cancer, neurodegeneration, and infectious ...
Xiaonan Liu, Lawrence Abad, Lopamudra Chatterjee, Ileana M. Cristea, Markku Varjosalo   +4 more
wiley   +1 more source

Effectiveness of N95 Mask Fit Testing for the Prevention of Severe Acute Respiratory Syndrome Coronavirus 2: A Retrospective Case-Control Study. [PDF]

Cureus
Fujimoto G, Obikane S, Kuboyama K.
europepmc   +1 more source

Eligibility for Nirmatrelvir/Ritonavir Among Adults With an Acute Care COVID‐19 Encounter: A Retrospective Cohort Study From Alberta, Canada

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 1, January 2026.
ABSTRACT Purpose To describe the characteristics of adults who had a severe coronavirus disease 2019 (COVID‐19) outcome during a timeframe that nirmatrelvir/ritonavir (NMV‐r; Paxlovid) was available, to assess medical eligibility and receipt of NMV‐r before presentation to acute care.
Sylvia Aponte‐Hao, Khanh Vu, Jason R. Randall, Karen J. B. Martins, Phuong Uyen Nguyen, Lynora Saxinger, Jenine Leal, Elissa Rennert‐May, Ellen Rafferty, Tyler Williamson, Scott W. Klarenbach   +10 more
wiley   +1 more source

Arteriovenous Thrombosis among Severe Acute Respiratory Syndrome Coronavirus 2 Infected Patients: An Observational Study at a University Hospital.

Ann Afr Med
AlAmri AS, AlShahrani MS, Hejazi TM, Abualola HA, Samarah AT, Almuaigel MF, AlDawsar FA, AlRashidi NS, AlGhamdi MA, Kabbani AH.   +9 more
europepmc   +1 more source

Coronavirus Disease 2019 Lineages in a Minimally Vaccinated Island Population: Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in Haiti. [PDF]

J Infect Dis
Mavian CN, Tagliamonte MS, Bassett M, Alam MT, Cash MN, Hitchings M, Louis R, Riva A, Zainabadi K, Deschamps MM, Liautaud B, Rouzier V, Fitzgerald DW, Pape JW, Morris JG, Salemi M.   +15 more
europepmc   +1 more source

Effect of Universal Masking on Non-Severe Acute Respiratory Syndrome Coronavirus 2 Healthcare-Associated Respiratory Viral Infections. [PDF]

Open Forum Infect Dis
Munigala S, Ching PR, Wood H, Waken RJ, Fox J, Gasama H, Russell R, Yarbrough ML, Warren DK.   +8 more
europepmc   +1 more source

Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB-Containing Vaccines. [PDF]

J Infect Dis
Chalkias S, McGhee N, Whatley JL, Essink B, Brosz A, Tomassini JE, Girard B, Edwards DK, Wu K, Nasir A, Lee D, Avena LE, Feng J, Deng W, Montefiori DC, Baden LR, Miller JM, Das R.   +17 more
europepmc   +1 more source